Pfizer, Allergan in Final Talks for Biggest Deal in Pharma History

Nov. 19, 2015

Pfizer and Allergan are in the final stages of merger discussions, according to CNBC sources, with an announcement expected the Monday after Thanksgiving.

The price being discussed is $370 to $380 per share, valuing Allergan at as high as $150 billion.

A $380 per share deal would beat out Pfizer’s $116 billion purchase of Warner-Lambert in 2000 as the biggest transaction in history between drug companies, according to Bloomberg-compiled data.

Additionally, buying Dublin-based Allergan would allow New York-based Pfizer to relocate outside the U.S. for tax purposes, a common strategy known as an inversion.

Read the CNBC report